SCHEMBL23732609

SCHEMBL23732609

CCc1cc(C)ccc1S(=O)(=O)Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.41
TRPV4 Q9HBA0 3/20 0.38
ALDH1A1 P00352 2/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MEP1B Q16820 1/20 0.35
NQO1 P15559 1/20 0.35
POR P16435 1/20 0.35
NR3C1 P04150 2/20 0.35
NR3C2 P08235 2/20 0.35
TAAR1 Q96RJ0 1/20 0.34
KMT2A Q03164 1/20 0.34
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4138945 0.83 RAPGEF4 (0.42) RAPGEF4ALDH1A1TSHRCASP1CASP7
SCHEMBL15965543 0.82 L3MBTL1 (0.42) RAPGEF4ALDH1A1TSHRCASP1CASP7
SCHEMBL30236538 0.80 RAPGEF4 (0.44) RAPGEF4ALDH1A1TSHRCASP1CASP7
Methylamine SCHEMBL28132703 0.80 RAPGEF4 (0.41) RAPGEF4TSHRCASP1CASP7SMN1; SMN2
SCHEMBL1607815 0.80 RAPGEF4 (0.44) RAPGEF4ALDH1A1TSHRCASP1CASP7
SCHEMBL1559677 0.80 KDM4E (0.45) RAPGEF4ALDH1A1TSHRCASP1CASP7
SCHEMBL11541207 0.80 ALDH1A1 (0.40) TRPV4ALDH1A1TSHRSMN1; SMN2LMNA
SCHEMBL30069489 0.80 KDM4E (0.45) RAPGEF4ALDH1A1TSHRCASP1CASP7
SCHEMBL29627448 0.79 TRPV4 (0.42) TRPV4ALDH1A1TSHRSMN1; SMN2KDM4E
SCHEMBL2426442 0.79 TRPV4 (0.42) TRPV4ALDH1A1TSHRSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3362448-B1 NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA INVENTIVA (FR) 2021-08-04 EP disclosed